Skip to main content
CI
NYSE Life Sciences

Cigna Confirms Strong 2026 Outlook with $30.25+ Adjusted EPS, Names New CEO

feedReported by Wiseek News
Sentiment info
Positive
Importance info
7
Price
$284.01
Mkt Cap
$74.845B
52W Low
$239.51
52W High
$350
Market data snapshot near publication time

summarizeSummary

Cigna Group confirmed its 2026 financial outlook, projecting adjusted income of at least $30.25 per share, with strong contributions expected from its Evernorth and Cigna Healthcare segments. This confirmation provides crucial clarity on the company's near-term financial performance and reinforces management's confidence. While the headline also notes Brian Evanko's appointment as CEO, this leadership transition was previously announced in an 8-K filing earlier today. The specific financial guidance is new and material, offering traders updated information for their positioning decisions.

At the time of this announcement, CI was trading at $284.01 on NYSE in the Life Sciences sector, with a market capitalization of approximately $74.8B. The 52-week trading range was $239.51 to $350.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


show_chartPrice Chart

Share this article

Copied!

feed CI - Latest Insights

CI
Mar 13, 2026, 4:36 PM EDT
Filing Type: DEF 14A
Importance Score:
7
CI
Mar 03, 2026, 3:03 PM EST
Source: Wiseek News
Importance Score:
7
CI
Mar 03, 2026, 7:42 AM EST
Filing Type: 8-K
Importance Score:
7
CI
Feb 26, 2026, 12:08 PM EST
Filing Type: 10-K
Importance Score:
8
CI
Feb 05, 2026, 6:15 AM EST
Filing Type: 8-K
Importance Score:
8